Eyal Shamir | Chief Executive Officer |
Ronen Tsimerman | Chief Financial Officer and Chief Operating Officer |
Richard Fine | Investigator of ICE3 Clinical Trial |
Ben Haynor | Alliance Global Partners |
Kemp Dolliver | Brookline Capital Markets |
Welcome to IceCure’s First Quarter 2022 Results Conference Call. Management will provide an overview of IceCure’s financial results as well as clinical and operational highlights.
On the call today are IceCure’s CEO, Eyal Shamir and CFO, Ronen Tsimerman. They are joined today by Dr. Richard Fine.